Bipolar Affective Disorder Clinical Trial
Official title:
Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.
Verified date | January 2020 |
Source | Centre Hospitalier Universitaire de Saint Etienne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Based in an embodied approach of cognition, several studies have highlighted a direct link between perception of an object or an emotion and the associated motor responses. This study investigated in patients suffering from bipolar affective disorders whether the perception of emotional words involves an automatic sensorimotor simulation of approach and avoidance behaviors, and whether the perception of an object involves an automatic sensorimotor simulation of object prehension (affordance). We hypothesize that, in this pathology, low level (sensorimotor) cognitive processes are preserved whereas high-level (attentional) are altered. 20 patients suffering from bipolar affective disorders and 20 healthy controls will be recruited. The main objective is the emergence of sensorimotor compatibility effects in approach-avoidance task with emotional stimuli (gain between compatible vs incompatible conditions).
Status | Completed |
Enrollment | 30 |
Est. completion date | August 21, 2018 |
Est. primary completion date | August 21, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility |
Inclusion Criteria: For patients: - Affiliated or entitled to a social security - Aged between 18 and 55 - Patients of both sexes suffering from bipolar disorders (DSM V criteria) whatever the subtype - Stabilized from a point of view clinical and therapeutic - Euthymic (score <7 at the Hamilton scale, and score <8 at Young's scale) - Must have given their informed consent before their participation in the study - Be right-handed (score> 14 on the laterality scale) For control group: - Affiliated or entitled to a social security - Must have given their informed consent before their participation in the study - Be right-handed (score> 14 on the lateral scale) - Aged 18 to 55 matched by age (± 5 years), sex, and on the study level of patients (years of schooling after primary school ± 2 years) Exclusion Criteria: For patients: - Thymic acute decompensation - Hamilton scale > 8, Young's scale > 9 - Montreal Cognitive Assessment (MOCA) <26 - History neurological pathology with cerebral impairment or serious somatic disease - Disorders related to the use of a psychoactive substance, as defined by the DSM-V (abuse, dependence or withdrawal) within 6 months. - IQ < 70 - History of head trauma For control group: - History of head trauma - Neurological pathology with cerebral impairment or serious somatic disease - Psychotropic treatment - Disorders related to the use of a psychoactive substance, as defined by the DSM-V (abuse, dependence or withdrawal) - IQ < 70 |
Country | Name | City | State |
---|---|---|---|
France | Chu Saint-Etienne | St Etienne |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Saint Etienne |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | response time for avoidance and affordance task | Comparison of response time for avoidance and affordance task between patients and healthy volunteers. | Months 24 | |
Secondary | response time for affordance task | Comparison of response time for affordance task between patients and healthy volunteers. | Months 24 | |
Secondary | correlations with age at onset of the disease, the number of thymic decompensations and the existence of psychotic symptoms | These informations were collected of the medical file. | Months 24 | |
Secondary | response time and cognitive tests | Correlation between response time and cognitive tests of patients and healthy volunteers. | Months 24 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03275714 -
Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder
|
N/A | |
Completed |
NCT01722344 -
Improving Work Outcome for People With Severe Mental Illness
|
N/A | |
Completed |
NCT01431092 -
Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia
|
Phase 4 | |
Completed |
NCT01315028 -
Bipolar Intervention Study: Cognitive Interpersonal Therapy
|
N/A | |
Terminated |
NCT00805493 -
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
|
Phase 2 | |
Completed |
NCT00436020 -
rTMS in the Treatment of Bipolar Depression
|
N/A | |
Withdrawn |
NCT00397605 -
Cannabinoids in Bipolar Affective Disorder
|
N/A | |
Recruiting |
NCT05860101 -
Compassion-Focused Therapy for Distressing Mood Swings: A Case Series
|
N/A | |
Recruiting |
NCT06176456 -
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia
|
N/A | |
Terminated |
NCT03310593 -
Cannabidiol as an Adjunctive Treatment for Bipolar Depression
|
Phase 2/Phase 3 | |
Recruiting |
NCT05406414 -
The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems
|
N/A | |
Completed |
NCT02773108 -
Somatic Comorbidities in Psychiatric Patients
|
||
Recruiting |
NCT00474357 -
Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy
|
N/A | |
Withdrawn |
NCT00327756 -
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
|
Phase 2 | |
Completed |
NCT02453217 -
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial
|
N/A | |
Completed |
NCT05683431 -
Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)
|
N/A | |
Not yet recruiting |
NCT05915312 -
Exosome for Early Diagnosis of Bipolar Affective Disorder
|
||
Completed |
NCT00186758 -
Transcranial Magnetic Stimulation in Bipolar Depression
|
Phase 4 | |
Completed |
NCT02083978 -
Bipolar Research Study Using MR Imaging
|
N/A | |
Completed |
NCT00683709 -
Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder
|
Phase 4 |